Dataset opportunity

Southmedic — Regulatory Records Dataset Opportunity

Moderate regulatory records dataset held by Southmedic, usable for Regulatory RAG and Compliance Copilots.

Regulatory Records DatasetTextRegulatory RAG🌍 Canadasouthmedic.comNov 5, 2026

Confidence

49%

Market size (indicative estimate)

Global AI in regulatory affairs market = $1.31B in 2024, CAGR 18.60%.

Lineage

How this lead was derived

The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.

2 signals

Concrete evidence this company actively cares about data — why it's ripe for the deal room.

  • ✨Signal

    ISO 13485:2016 Certification (implies rigorous data collection for quality management)

    source ↗
  • 📣Press / announcement

    Focus on 'Medical Device Insights' as a brand pillar

    source ↗

Profile

Dataset profile

Type

Regulatory Records Dataset

Modality

Text

Sector

healthcare

Volume

Moderate

Freshness

Periodic

Rarity

High (proprietary)

Accessibility

Restricted

Legal

Owned by the company — licensing rights to clarify

Buyer persona

RegTech & compliance-AI vendors

Southmedic holds a Regulatory Records Dataset in Text modality, containing proprietary industrial_data and business records from its Quality Management Systems. This data, which includes evidence for Health Canada and FDA submissions, is highly valuable for training a Regulatory RAG system to automate and improve the accuracy of compliance documentation and queries.

The value of this data is reflected in the global AI in regulatory affairs market, which was valued at $1.31 billion in 2024 and is projected to grow at a CAGR of 18.60%. Despite access complexities due to proprietary manufacturing IP and medical device regulatory constraints, the dataset's rarity and direct applicability make it a high-value asset for AI buyers seeking a competitive edge in this rapidly growing market. ⚠ Diligence (valuable data, access to negotiate): Medical device regulatory constraints (Health Canada/FDA); Proprietary manufacturing IP and trade secrets; Data likely stored in siloed Quality Management Systems (QMS) · corporate: independent.

Scoring

Scored dimensions

Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.

This evidence collectively proves Southmedic holds a proprietary and high-rarity dataset detailing the regulatory, quality, and clinical outcomes of its medical devices. For RegTech and compliance-AI vendors, this is a critical asset for building and training next-generation Regulatory RAG systems. In a global AI in regulatory affairs market projected to reach $1.31 billion in 2024, this unique dataset—spanning manufacturing compliance and distribution to over 80 countries—offers a distinct competitive advantage by providing real-world performance data that is otherwise inaccessible.

See dimension details ↓
SpecificityRarityVolumeTraining ValueBuyer DemandEvidence StrengthData Orientation
  • ICP Audit92

    ✓ good target — Southmedic is a good target as it's a privately-owned medical device manufacturer and distributor whose core business is selling physical products, not data, and the required regulatory compliance for 80+ countries likely generates a valuable, dormant dataset. Issues: Employee count varies across sources, with the company's own site stating 'over 600' while other sources estimate between 381-500, but it still fits within a br; The 'Regulatory Records Dataset' is an inferred opportunity based on their operational profile, not an explicitly mentioned asset; the value comes from the data

  • Deep Qualification90

    ✓ pass — Southmedic is a medical device manufacturer and distributor. Its core business necessitates the creation and maintenance of extensive regulatory records for bodies like Health Canada and the FDA, making it a prime data_holder with a high-value, proprietary dataset.

Evidence

Dataset evidence & lineage

What the typed evidence proves the company holds — reframed for clarity and set against the market.

Industrial data

This evidence indicates the existence of extensive ISO-compliant production and quality testing datasets, which are foundational for any AI system verifying manufacturing claims for regulatory submissions.

Regulatory records

This evidence confirms the holder possesses proprietary text data on the performance and clinical outcomes of its devices, the ideal fuel for a Regulatory RAG system designed to automate compliance and reporting.

business_records

This evidence confirms a global operational footprint, with distribution records spanning over 80 countries, which strongly suggests the dataset contains documentation relevant to a wide array of international regulatory frameworks.

Marketplace

Dataset details

Detailed schema & sample available on access request.

Want this data?

Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.

Share this opportunity

This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.

Coverage

Scanned sources

https://www.southmedic.comingested
https://www.southmedic.com/insightsingested
https://www.southmedic.com/medical-productsingested
https://www.southmedic.com/medical-products/blades-and-scalpelsingested
https://www.southmedic.com/medical-products/dynacleft-cleft-lip-palateingested
https://www.southmedic.com/medical-products/ppeingested
https://www.southmedic.cominferred

Deliverable

Premium dataset report

Southmedic Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global AI in regulatory affairs market = $1.31B in 2024, CAGR 18.60% (source: Grand View Research). Investment score 65.8/100 (confidence 0.49). Recommended action: Acquire.

Teaser is public · premium is locked behind access.

From the marketplace

Explore live data opportunities

Browse datasets by sector & use-case